Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719146 · ClinicalTrials.gov registry record
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 134
- Enrollment target
NCT01719146: Completed study, sponsored by University of Louisville.
NCT01719146 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01719146 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively collect data on doses of Erythropoietic Stimulating Agents (ESA) and Intravenous Iron, and the markers of erythropoietic activity and iron status. These data will be used to derive mathematical models which will subsequently guide dosing of both agents, such that a desired therapeutic outcome is achieved in every patient, while minimizing patient exposure to both agents.
Primary Outcome
Weekly Hemoglobin Concentration
Interventions
- OTHER Specimen collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2013-01 |
| Est. Completion | 2021-06-05 |
What the finished NCT01719146 record still lists
NCT01719146 is an observational study that tracks outcomes without assigning an intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Specimen collection is the first listed.
NCT01719146 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01719146 about?
NCT01719146 is a clinical study titled "Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease". The purpose of this study is to prospectively collect data on doses of Erythropoietic Stimulating Agents (ESA) and Intravenous Iron, and the markers of erythropoietic activity and iron status. These data will be used to derive mathematical models which will subsequently guide dosing of both agents, ...
What is the current status of trial NCT01719146?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2013-01. Estimated completion is 2021-06-05.
What interventions are being tested in trial NCT01719146?
The interventions under investigation include: Specimen collection (OTHER).
Who is sponsoring clinical trial NCT01719146?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia